HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

Remifemin

from rhizome of black cohosh, Cimicifuga racemosa; has LH suppressive effect in menopausal women

Networked: 9 relevant articles (2 outcomes, 2 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Complex Mixtures: 1906
- Biological Products
  - Plant Preparations: 622
    - Plant Extracts: 3916
      - Remifemin: 9
Pharmaceutical Preparations
- Plant Extracts: 3916
  - Remifemin: 9
Eukaryota
- Viridiplantae
  - Streptophyta
    - Embryophyta
      - Tracheophyta
        Magnoliopsida
        Ranunculales
        Ranunculaceae
        Cimicifuga
        Remifemin: 9

Experts

1.	Bai, Wenpei: 3 articles (01/2018 - 01/2013)
2.	Jia, Jing: 2 articles (01/2018 - 01/2013)
3.	Qin, Lihua: 2 articles (01/2018 - 01/2013)
4.	Wang, Ke: 2 articles (01/2018 - 01/2013)
5.	Ross, Stephanie Maxine: 2 articles (11/2014 - 01/2012)
6.	Geng, Li: 2 articles (01/2014 - 08/2009)
7.	Chen, Dao-Bao: 1 article (06/2019)
8.	Deng, De-Hou: 1 article (06/2019)
9.	Huang, Qiang: 1 article (06/2019)
10.	Liang, Chen-Lu: 1 article (06/2019)

Related Diseases

1.	Leiomyoma (Uterine Fibroids) 11/01/2014 - "Both therapies demonstrated efficacy in relieving menopausal symptoms; however, isopropanolic black cohosh (Remifemin) seems to be a more appropriate choice in alleviating menopausal symptoms in women with uterine fibroid. " 06/28/2019 - "In addition, the incidence of cervical cyst in Remifemin group was higher than that in control group (P = 0.02), and there was no significant difference in the other gynecological complications, including endometrial thickening, ovarian cyst or uterine fibroid (P > 0.05). "
2.	Myoma 01/01/2014 - "Our results suggest that iCR (Remifemin) is a valid herbal medicinal product in patients with uterine myomas as it provides adequate relief from menopausal symptoms and inhibits growth of the myomas in contrast to tibolone. "
3.	Postmenopausal Osteoporosis 01/01/2013 - "This study aims to evaluate the effects of Remifemin (isopropanolic extract of Cimicifuga Racemosa) on postmenopausal osteoporosis. " 01/01/2013 - "In conclusion, Remifemin may demonstrate equivalent effects to estradiol valerate in terms of preventing postmenopausal osteoporosis."
4.	Endometriosis 10/16/2014 - "The aim of this study was to investigate clinical efficacy and safety of Remifemin on peri-menopausal symptoms in endometriosis patients with a post-operative GnRH-a therapy. " 10/16/2014 - "Compared with Tibolone, Remifemin had a similar clinical efficacy and was safer for the peri-menopausal symptoms induced by GnRH-a in endometriosis patients." 10/16/2014 - "We treated 116 women who had endometriosis with either Remifemin (n=56) 20 mg bid po or Tibolone (n=60) 2.5 mg qd po for 12 weeks after GnRH-a injection. " 10/16/2014 - "Efficacy and safety of remifemin on peri-menopausal symptoms induced by post-operative GnRH-a therapy for endometriosis: a randomized study versus tibolone."
5.	Hot Flashes 01/01/2018 - "Standardized isopropanolic black cohosh (Actaea racemosa; Remifemin) can also relieve menopausal symptoms, such as hot flashes and sweating. " 01/01/2012 - "This clinical study confirmed previous results, which clearly indicate the efficacy and tolerability of this proprietary black cohosh extract (Remifemin) in addressing menopausal symptoms, particularly hot flashes."

Related Drugs and Biologics

1.	tibolone
2.	Gonadotropin-Releasing Hormone (GnRH)
3.	Estradiol (Delestrogen)
4.	femicur N
5.	black cohosh root extract

Related Therapies and Procedures

1.	Therapeutics
2.	Hormone Replacement Therapy (Therapy, Hormone Replacement)
3.	Ovariectomy (Oophorectomy)